期刊文献+

HIV1/2抗体与P24抗原联合检测的意义研究 被引量:5

Significance of combined assay of Anti-HIV1,2 with P24 antigen
原文传递
导出
摘要 目的研究HIV1/2抗体与P24抗原联合检测对临床诊断的影响。方法自2006年1月-2011年3月分别收集ELISA法检测HIV1/2抗体吸光度(OD值)为临界值及大于等于阳性对照的患者血清33、29份,采用电化学发光法联合检测HIV1/2抗体与P24抗原(HIVCOM),追踪患者免疫印迹HIV确证试验结果,研究HIV1/2抗体与P24抗原联合检测对临床诊断的影响。结果 33例临界值吸光度患者中27例HIV1/2抗体与P24抗原阳性,6例阴性,29例大于等于阳性对照值吸光度的患者中28例阳性,1例阴性,免疫印迹HIV确证试验的检测结果与联合检测HIV1/2抗体及P24抗原结果一致。结论 HIV1/2抗体与P24抗原联合检测较ELISA法能够更早更准确的发现HIV感染,对临床的早期诊断和治疗具有重要的意义及应用价值。 OBJECTIVE To study the effect of combined assay of anti-HIV1,2 and P24 antigen on clinical diagnosis.METHODS A total of 33 and 29 examples of patient serum whose absorbency(OD value) on HIV in ELISA were medi-value or more than positive contral from Jan 2006 to Mar 2011 were separately collected,their anti-HIV1,2 and P24 antigen(HIVCOM) were detected by electrochemistry,tracks for their results of western blot were made,the effects on clinical diagnosis of combined assay of anti-HIV1,2 and P24 antigen were studied.RESULTS There were 27 cases of positive anti-HIV1,2 and P24 antigen,6 negative cases among the 33 patients and 28 positive and 1 negative of the 29 patients by electrochemistry,the results of HIV confirmatory by western blot assay were the same with that of anti-HIV1,2 and P24 antigen by combined assay.CONCLUSION The combined assay of anti-HIV1,2 and P24 antigen can discover the infection of HIV earlier and definitely than ELISA,it has important significance in clinical diagnosis and therapy at the early stage.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第9期1786-1788,共3页 Chinese Journal of Nosocomiology
关键词 HIV1/2抗体 P24抗原 电化学发光 免疫印迹试验 Anti-HIV1 2 P24 antigen Electrochemistry Western blot
  • 相关文献

参考文献7

  • 1杨晓莉,李敬云.HIV感染确认的现状和发展趋势[J].中国艾滋病性病,2007,13(6):585-587. 被引量:34
  • 2Peng H, Erdmann N, Whitney N, et al. HIV-1-infected and/ or immune activated macrophages regulate astrocyte SDF 1 production through IL-1 beta[J]. Glia,2006,54(6):619-629.
  • 3Scott I.E, Noble LD, Moloi J, et al. Evaluation of the Abbott m2000 Real Time Human Immunodeficency Virus Type I(HIV-1) Assay for HIV Load Monitoring in South Africa Compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrepCobas TaqMan HIV 1, and BioMerieux NucliSENS EasyQ HIV-1 Assays[J]. J Clin Micro-biol,2009,47(7) :2209-2217.
  • 4许文燕,邱茂锋,佐合拉.吐尔地,邢文革,蒋岩.第四代HIV抗原抗体酶联检测试剂缩短HIV检测窗口期的研究[J].中华检验医学杂志,2007,30(3):284-287. 被引量:63
  • 5Leung TW, Mak D, Wong KH, et al. Molecular epidemiology demonstrated three emerging clusters of human immunodeficiency virustype 1 subtype B infection in HongKong[J]. AIDS Res Hum Retroviruses,2008,24(7) :903-910.
  • 6孙丽君,刘安,吴昊.HIV耐药的临床和基础研究进展[J].中国艾滋病性病,2011,17(1):81-84. 被引量:1
  • 7Kearney M, Yu S, Shao W, etal. HIV-1 plasma virus diversity persists despite suppression with antiretroviral therapy [J]. Antivir Ther, 2009,14 (Suppll) :A8.

二级参考文献58

  • 1黑发欣,张启云,孙伟东,边新玲,张琴,刘海林,贺雄.HIV抗体筛查实验阳性 确认实验可疑和阴性标本的对比分析[J].中国艾滋病性病,2006,12(1):4-6. 被引量:31
  • 2Kearney M, Yu S, Shao W, et al. HIV-1 plasma virus diversity persists despite suppression with antiretroviral therapy[J]. Antivir Ther 2009, 14 Suppl 1:A8.
  • 3Dinoso J, Jones J, McMahon D, et al. Antiretroviral intensifica- tion does not reduce persistent HIV-1 viremia on therapy[J]. Antivir Ther 2009, 14 Suppl 1:A12.
  • 4Cossarini F, Wiegand A, Mican J, et al. Markers of cellular immune activation do not correlate with levels of residual viremia in patients on long-term suppressive antiretroviral therapy[J]. Antivia Ther 2009,14 Suppl 1 : A10.
  • 5De Castro N, Braun J, Charreau I, et al. Switch from enfuvirtide to raltegravir in highly treatment-experienced HIV-l-infected patients: a randomized open-label non-inferiority trial, Easier-ANRS 138.16th Conference on Retroviruses and Opportunistic Infections[A]. 8- 11 February 2009, Montreal, QC, Canada. Abstract 572.
  • 6Palmer S, King M, Wiegand A, et al. Longitudinal dynamics of persistent viremia in elite controller patients versus patients on suppressive therapy[J]. Antivir Ther 2009,14 Suppl 1 :A6.
  • 7Hunt P W, Hatano H, Sinclair E,et al. HIV specific CD4+Tcells may contribute to viral persistence in HIV-infeeted elite controllers[J]. Antivir Ther 2009; 14 Suppl 1:A7.
  • 8Rullas J, Bermejo M, Garcia-P6rez J, et al. Prostratin induces HIV activation and downregulates HIV receptors in peripheral blood lymphocytes[J]. Antivir Ther 2004,9:545 554.
  • 9Bedoya L M, Mdrquez N, Martinez N, et al. SJ23B, a jatrophane diterpene activates classical PKCs and displays strong activity against HIV in vitro[J]. Bioehem Pharmaeol 2009,77:965-978.
  • 10Smith A J, Schacker T W, Sivertson M B, et al. The role of chitinase-3-1ike-1 in bacterial transloeation during HIV-1 infection [J]. Antivir Ther 2009, 14 Supp; l:Ag.

共引文献95

同被引文献48

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部